GenSight Biologics Secures a €35 Million Credit Facility From the European Investment Bank to Support the Launch of LUMEVOQ® in Europe Read more about GenSight Biologics Secures a €35 Million Credit Facility From the European Investment Bank to Support the Launch of LUMEVOQ® in Europe
Invitation to presentation of 3rd quarter results 2022 Read more about Invitation to presentation of 3rd quarter results 2022
Invitation to Huddlestock Fintech's 3Q 2022 results presentation, Thursday 10 November 2022 Read more about Invitation to Huddlestock Fintech's 3Q 2022 results presentation, Thursday 10 November 2022
Van Lanschot Kempen: third-quarter trading update Read more about Van Lanschot Kempen: third-quarter trading update